HPV Vaccine Provides Little Benefit for Older Women (3/9/2010)
Researchers from Costa Rica have reported that women over the age of 40 are not likely to benefit from vaccination to prevent human papillomavirus (HPV). The details of this study were published in the March 3, 2010 issue of the Journal of the National Cancer Institute.

Cervarix® Vaccination Against HPV Lasts at Least Six Years (12/7/2009)
Researchers affiliated with the GlaxoSmithKline Vaccine HPV-007 Study Group have reported that Cervarix® [human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine] has “high and sustained immunogenicity, and a favorable safety” profile for up to 6.4 years following administration. The details of this study appeared in an early online publication in the Lancet on December 3, 2009.

ACOG Publishes New Guidelines for Cervical Cancer Screening (11/23/2009)
The American College of Obstetricians and Gynecologists (ACOG) has published new guidelines for cervical cancer screening. The details of these new recommendations will be published in the December 2009 issue of Obstetrics and Gynecology.

Primary Care Physicians May Be Ordering More Pap Smears Than Necessary (11/13/2009)
Researchers from the National Institutes of Health have reported that primary care physicians overuse Pap smear testing and are not following current recommendations. The details of this study appeared in the November 3, 2009 issue of the Annals of Internal Medicine.

Vaccination for HPV in Females Associated with a Decline in Genital Warts in Females and Males (10/29/2009)
Researchers from Australia have reported a decline in the number of cases of genital warts in women and men since the initiation of quadrivalent vaccination to prevent human papillomavirus (HPV) infection. The details of this study appeared in an early on-line publication in Sexually Transmitted Infections on October 16, 2009.